HOME >> BIOLOGY >> NEWS
UV Skin Damage In A Different Light

Despite all the warnings to avoid exposure to the sun and to wear sunscreen, scientists don't really know how the sun damages our skin. Now, they're a bit closer to the answer.

Two scientists recently discovered that sunlight triggers a harmful reaction when it strikes a molecule in our skin--ironically a molecule once thought to be "nature's sunscreen." The work suggests the science behind the sagging, leathery skin typical of long-term sun worshipers, and may also shed light on how ultraviolet light causes skin cancer.

"We studied a natural component of human skin exposed to ultraviolet light and uncovered a new chemical reaction that may contribute to aging [of the skin] and cancer," said Dr. John Simon, who led the study.

The research will appear in the September 1 issue of the Proceedings of the National Academy of Sciences. The work was conducted at the University of California, San Diego by Dr. John D. Simon (who is now at Duke University), and his graduate student Kerry Hanson (who is now a postdoctoral fellow at the University of Illinois at Urbana-Champaign).

The sun's harmful rays come in two flavors: ultraviolet A and ultraviolet B. Evidence mounts that ultraviolet A and B both play a role in causing skin cancer and photoaging, which is characterized by deep, premature wrinkles, thickened skin, and age spots.

Time, gravity, and heredity notwithstanding, "something like 90 percent of all the visible signs of aging are from ultra-violet sources," said Dr. Kerry Hanson. "Photoaging is not just a cosmetic effect. It destroys the integrity of your skin."

The focus of this study is the sun-sensitive molecule called trans-urocanic acid (t-UA). Formed in the top layer of the skin, t-UA molecules cover our bodies, acting like antennae for light. In the 1950s, urocanic acid was hailed as a "natural sunscreen" because it absorbs ultraviolet B light. It was thus thought to protect against damage by such rays, which can potentially
'"/>

Contact: Alisa Machalek
machalea@nigms.nih.gov
(301) 496-7301
NIH/National Institute of General Medical Sciences
1-Sep-1998


Page: 1 2 3

Related biology news :

1. Damaged genes in aging human brain provide clues to cognitive decline
2. Damage from acid rain pollution is far worse than previously believed
3. Damaged DNA synthesis enzyme shown to cause progressive muscle weakening
4. Damaged spinal cord found to have greater potential for nerve regrowth than thought possible
5. Concern Unfounded About Damage From Vitamin C
6. Enzyme Required To Prolong Life In Worms Identified By Researchers At Columbia; Key Enzyme Appears To Protect Animal Cells From Oxidative Damage
7. UCSF Scientists Report On A Transcription Factor That Could Stimulate Heart Cells To Repair Damage Caused By Heart Attacks Or Birth Defects
8. Jefferson Scientists Find Further Proof Of Damage To The FHIT Gene In Breast Cancers
9. Study Indicates Adolescent Smokers Are More Susceptible To Long-Term DNA Damage From Smoking Than Adults Smokers
10. Spider Venom Stops Stroke Brain Damage
11. Common Respiratory Virus Identified As One Cause Of Heart Muscle Damage That Can Lead To Sudden Death

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Skin Damage Different Light

(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:4/27/2015)... Profile Solutions, Inc. (OTC: PSIQ), a leading ... pleased to announce that Dr Gerry Bedore ... of its scientific advisory board. ... leader in technology-enhanced learning models. He was a co-founder ... studies and books focused on online student success and ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
(Date:5/21/2015)... NOVATO, Calif. , May 21, 2015 /PRNewswire-USNewswire/ ... Orrin Hatch (R-UT) and Amy ... Product Extensions Now Accelerating Cures & Treatments, or ... 150 rare disease patient advocacy organizations, this bipartisan ... effective, and affordable medicines to rare disease patients ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
Cached News: